Executive Summary
The 15 proxy filings reveal a mix of corporate actions and governance shifts, with a notable cluster of reincorporation proposals (Trulieve, Granite Ridge) and sub-adviser changes (Liberty All Star funds) signaling strategic restructuring. Period-over-period compensation data shows sharp divergence: Kingstone's CEO pay surged 61.5% YoY driven by stock awards (+345%), while Palatin froze equity grants entirely.
Portfolio liquidation trends at TCW Direct Lending (portfolio down to $249.7M, 5 debt obligors) contrast with Anterix's zero-debt balance sheet and $127M in contracted proceeds. Insider trading activity is sparse across filings, but the absence of insider selling at Anterix and McGraw Hill supports management confidence post-IPO. Forward-looking catalysts include August 2026 annual meetings for 10 companies, with key votes on reverse splits (CytoSorbents), stock plan expansions (Anterix, PetMed), and auditor ratifications. The most material development is Trulieve's redomiciliation to Delaware, which could unlock institutional ownership and tax benefits, while TCW's winding-down extension highlights terminal risk in BDC structures.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: DEF 14A
Tracking the trend? Catch up on the prior US Executive Compensation Proxy SEC Filings digest from June 18, 2026.
Investment Signals (10)
- Anterix ↓ (BULLISH)▲
Zero-debt balance sheet with $127M in contracted proceeds received in FY2026, FCC approval unlocking full 10 MHz 900 MHz band for broadband deployment, and proposed stock plan expansion signaling growth investment
- Kingstone ↓ (BULLISH)▲
CEO compensation surged 61.5% YoY to $1.87M, driven by 345% increase in stock awards, aligning management with long-term shareholder value creation; Chief Actuary's bonus declined 12.6% YoY, suggesting cost discipline
- McGraw Hill ↓ (BULLISH)▲
CEO transition from Simon Allen to Philip Moyer with retention of Allen as Chair, combined with IPO-era clawback policy adoption, signals governance maturity and leadership continuity
- Palatin Technologies ↓ (BEARISH)▲
No new stock options or RSUs granted to directors or NEOs in FY2025, while audit fees rose 32.9% YoY to $670K, indicating increased regulatory scrutiny without equity incentive alignment
- TCW Direct Lending ↓ (BEARISH)▲
Management fee waived since 2023 ($0 earned in 2025) as portfolio shrinks to $249.7M with only 5 debt obligors and 6 equity issuers, signaling wind-down urgency and limited upside
- Trulieve Cannabis ↓ (BULLISH)▲
Redomiciliation from Canada to Delaware could reduce regulatory complexity and attract U.S. institutional investors, with special meeting on August 5, 2026
- CytoSorbents ↓ (BEARISH)▲
Reverse stock split proposal (1:5 to 1:20 range) indicates management's attempt to maintain Nasdaq listing, but signals financial distress and potential dilution risk
- PetMed Express ↓ (NEUTRAL)▲
Amendment to 2024 Omnibus Incentive Plan to increase shares reserved for issuance suggests future equity compensation needs, but as a smaller reporting company with public float under $250M, dilution risk is elevated
- Liberty All Star Funds (BULLISH)▲
Sub-adviser change from Sustainable Growth Advisers to Loomis Sayles for large cap growth equity, with same fee structure, could improve performance without cost increase
- AIM ImmunoTech ↓ (BEARISH)▲
Warrant inducement transaction raised $3.5M gross proceeds at $0.48/share with new Class H warrants at $0.60 strike, indicating capital needs and potential dilution of 19.99%+ of outstanding stock
Risk Flags (8)
- TCW Direct Lending/Portfolio Wind-Down↓ [HIGH RISK]▼
Portfolio declined to $249.7M with only 5 debt obligors and 6 equity issuers; management fee waived since 2023; supermajority vote needed for extension beyond September 2026
- CytoSorbents/Reverse Split Risk↓ [HIGH RISK]▼
Reverse stock split ratio of 1:5 to 1:20 at Board discretion without further shareholder approval, valid for one year; no financial results disclosed, raising transparency concerns
- AIM ImmunoTech/Dilution Risk↓ [HIGH RISK]▼
Issuance of more than 19.99% of outstanding common stock upon exercise of Class H warrants; $3.5M gross proceeds insufficient for clinical-stage biotech operations
- Palatin Technologies/Equity Incentive Gap↓ [MEDIUM RISK]▼
No stock options or RSUs granted to directors or NEOs in FY2025, potentially misaligning incentives; audit fees up 32.9% YoY suggesting higher compliance costs
- Kingstone/Compensation Disparity↓ [MEDIUM RISK]▼
CEO compensation up 61.5% YoY while Chief Actuary's bonus declined 12.6%, creating potential retention risk for key actuarial talent
- Hour Loop/Governance Risk↓ [MEDIUM RISK]▼
Only 3 of 5 directors deemed independent; CEO Sam Lai stands for election; non-routine director election means brokers cannot vote uninstructed shares, risking low turnout
-
Trustees and executive officers collectively own less than 1% of shares, with no 5%+ shareholders, indicating lack of aligned ownership
- Granite Ridge Resources/Reincorporation Uncertainty↓ [MEDIUM RISK]▼
Reincorporation from Delaware to Texas by conversion requires majority of outstanding shares voted FOR; virtual-only special meeting may suppress retail participation
Opportunities (8)
- Anterix/900 MHz Spectrum Monetization↓ (OPPORTUNITY)◆
FCC approval enabling full 10 MHz broadband deployment, zero debt, $127M contracted proceeds received in FY2026; stock plan expansion suggests growth phase; annual meeting catalyst August 2026
- Trulieve Cannabis/Redomiciliation Catalyst↓ (OPPORTUNITY)◆
Redomiciliation to Delaware could unlock U.S. institutional investment and tax benefits; special meeting August 5, 2026; dissent rights deadline July 31, 2026 creates arbitrage opportunity
- Liberty All Star Growth Fund/Sub-Adviser Upgrade↓ (OPPORTUNITY)◆
Loomis Sayles replacing Sustainable Growth Advisers for large cap growth equity; same fee structure paid by AAI, not the fund; potential performance improvement without cost drag
- McGraw Hill/Post-IPO Governance Strength↓ (OPPORTUNITY)◆
New CEO Philip Moyer with IPO-era clawback policy and Code of Ethics; say-on-pay vote and annual frequency recommendation signal shareholder-friendly governance
- Kingstone/Cumulative Voting Arbitrage↓ (OPPORTUNITY)◆
Stockholders can cumulate votes for director elections; with CEO compensation up 61.5% and virtual meeting, activist investors could leverage cumulative voting to influence board composition
- PetMed Express/Omnibus Plan Expansion↓ (OPPORTUNITY)◆
Amendment to increase shares under 2024 Omnibus Incentive Plan could support talent retention; as smaller reporting company with low public float, potential for value creation if growth initiatives succeed
- Tharimmune/Board Refreshment↓ (OPPORTUNITY)◆
Three new director nominees (Sean Galvin, Rishi Nangalia, Pamela L. Carter) replacing outgoing directors; combined Chairman/CEO role maintained with majority-independent board; potential for strategic pivot
- Granite Ridge Resources/Texas Reincorporation↓ (OPPORTUNITY)◆
Reincorporation to Texas may reduce legal costs and align with operational base; virtual special meeting August 4, 2026; 131.9M shares outstanding with simple majority vote required
Sector Themes (6)
- Reincorporation Wave◆
Two companies (Trulieve Cannabis, Granite Ridge Resources) seek to redomicile from Canada/Delaware to Delaware/Texas respectively, signaling a trend toward jurisdictional optimization for tax and regulatory benefits; both have special meetings in early August 2026
- Sub-Adviser Rotation in Closed-End Funds◆
Both Liberty All Star Equity Fund and Liberty All Star Growth Fund propose replacing Sustainable Growth Advisers with Loomis Sayles, indicating dissatisfaction with large cap growth performance and a shift toward larger, more established asset managers
- Compensation Divergence in Small Caps◆
Kingstone (+61.5% CEO pay) and Palatin (zero equity grants) represent opposite ends of compensation strategy; Kingstone uses stock awards to align incentives while Palatin's freeze may signal cash conservation or governance issues
- Portfolio Wind-Down vs. Growth Investment◆
TCW Direct Lending (portfolio shrinking to $249.7M, fee waiver) contrasts with Anterix ($127M contracted proceeds, zero debt, spectrum expansion), highlighting the divergence between liquidating BDCs and growth-stage infrastructure plays
- Dilution Risk Across Micro-Caps◆
CytoSorbents (reverse split up to 1:20), AIM ImmunoTech (19.99%+ warrant dilution), and PetMed Express (stock plan expansion) all signal potential shareholder dilution, a common theme among cash-constrained small caps seeking to maintain listings or raise capital
- Virtual Meeting Standardization◆
All 10 newly filed proxies specify virtual-only annual meetings, reflecting permanent adoption of pandemic-era practices; this reduces shareholder engagement but lowers costs, with implications for activist campaigns and vote outcomes
Watch List (8)
-
Special meeting August 5, 2026 for redomiciliation vote; dissent rights deadline July 31, 2026; watch for institutional shareholder voting patterns and potential arbitrage
-
Annual meeting August 13, 2026 with reverse split vote; watch for Board's final split ratio and subsequent Nasdaq compliance status
- Liberty All Star Funds👁
Joint annual meeting August 26, 2026 for sub-adviser approval; watch for Loomis Sayles performance relative to Sustainable Growth Advisers post-transition
- 👁
Annual meeting August 2026 (date TBD) with stock plan amendment vote; watch for spectrum deployment milestones and further contract announcements
-
Unitholder vote on term extension before September 19, 2026; watch for portfolio liquidation pace and potential asset sales
-
Special meeting July 2026 for warrant issuance approval; watch for subsequent capital raises and clinical trial updates
-
Special meeting August 4, 2026 for Texas reincorporation; watch for shareholder approval margin and post-reincorporation governance changes
-
Annual meeting August 5, 2026 with say-on-pay vote; watch for shareholder dissent on CEO compensation given 61.5% increase
Filing Analyses
(15)
25-06-2026
TCW Direct Lending LLC is seeking unitholder approval to extend its term by one year through September 19, 2027, to continue winding down its remaining investment portfolio valued at $249.7 million as of March 31, 2026. The company also proposes ratifying Deloitte as its independent auditor for fiscal year 2026. The adviser has waived its management fee since 2023, resulting in $0 management fee earned for 2025, but the company faces a declining portfolio with only 5 debt obligors and 6 equity issuers remaining.
- · The company's initial term was six years, expiring September 19, 2020, and has been extended multiple times; current term expires September 19, 2026.
- · Extension requires approval of a supermajority (more than 66-2/3%) of outstanding units.
- · Two debt investments were fully repaid and one had two partial exits since March 31, 2025.
- · The adviser has waived the management fee for all periods from and after December 31, 2022.
- · The incentive fee structure includes a 9% hurdle rate and a 20% catch-up and thereafter 20% of additional distributions.
- · If the term is not extended, the company may face forced liquidation or use of a liquidating trust.
- · The company does not expect to call additional investor capital for follow-on investments; it will use existing cash and credit facility availability.
25-06-2026
Anterix Inc. filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting on August 4, 2026, highlighting significant operational progress during fiscal 2026, including FCC approval enabling broadband deployment across the full 10 MHz of the 900 MHz band and several spectrum sale agreements worth $23.9 million combined. However, the filing also reveals that the company's accumulated deficit remains substantial, and while the balance sheet is strong with zero debt and $127 million in contracted proceeds received, shareholder dilution may increase with a proposed amendment to the 2023 Stock Plan to add shares.
- · FCC Report & Order secured enabling broadband deployment across the full 10 MHz of the 900 MHz band.
- · Zero debt balance sheet with $127 million in contracted proceeds received in Fiscal 2026.
- · Proposed Amendment No. 2 to the 2023 Stock Plan to increase shares available for issuance.
- · Texas-New Mexico Power agreement expanded coverage to more than 93% of Texas counties.
- · Annual Meeting scheduled for August 4, 2026, held virtually.
- · Record date for voting is June 11, 2026.
25-06-2026
Kingstone Companies, Inc. filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Stockholders to be held virtually on August 5, 2026. The meeting will include the election of six directors, ratification of CBIZ CPAs P.C. as independent auditor for FY2026, and a non-binding advisory vote on executive compensation. CEO Meryl S. Golden's total compensation increased 61.5% to $1,871,100 in 2025 from $1,158,658 in 2024, driven by a 41.0% increase in bonus and a 345.3% increase in stock awards; however, Chief Actuary Sarah Chen's total compensation rose only 18.4% to $838,430, with her bonus declining 12.6% year-over-year.
- · Annual Meeting will be held virtually on August 5, 2026 at 9:00 a.m. local time via www.virtualshareholdermeeting.com/KINS2026.
- · Record date for voting is June 12, 2026; proxy materials mailed on or about June 25, 2026.
- · Stockholders have cumulative voting rights for director elections; a stockholder must request a proxy card to cumulate votes.
- · Proposals include: (1) election of six directors, (2) ratification of CBIZ CPAs P.C. as auditor for FY2026, (3) non-binding advisory vote on executive compensation.
- · CEO Meryl S. Golden's all other compensation was $26,000 in 2025 (up from $25,800 in 2024).
- · Chief Actuary Sarah Chen's all other compensation was $14,000 in 2025 (up from $7,838 in 2024).
- · Sarah Chen received $12,400 in option awards in 2024 but none in 2025.
- · The filing notes that broker non-votes will have no effect on Proposals 2 and 3, while abstentions will count as negative votes.
25-06-2026
PetMed Express, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting to be held virtually on August 11, 2026. The meeting will cover the election of four directors, an advisory vote on executive compensation, ratification of Baker Tilly US, LLP as auditor for FY 2027, and an amendment to the 2024 Omnibus Incentive Plan to increase shares reserved for issuance. The company qualifies as a smaller reporting company with a public float under $250 million as of September 30, 2025.
- · Annual Meeting date: August 11, 2026 at 11:00 a.m. Eastern Time, virtual-only format via http://web.viewproxy.com/petmeds/2026.
- · Record date for voting: June 15, 2026.
- · Proxy materials first distributed on or about June 25, 2026.
- · Company qualifies as a smaller reporting company as of September 30, 2025 due to public float under $250 million.
- · Proposal 4 seeks to amend the 2024 Omnibus Incentive Plan to increase shares of common stock reserved for issuance.
25-06-2026
McGraw Hill, Inc. filed its DEF 14A proxy statement for the fiscal year ended March 31, 2026, seeking stockholder advisory votes on executive compensation (say-on-pay) and the frequency of such votes (recommending every one year). The filing details the retirement of former CEO Simon Allen effective December 30, 2025, and the appointment of Philip Moyer as President and CEO, along with the appointment of Tracey Tiska as CHRO in July 2025. The company also discloses its Code of Ethics and a Compensation Recovery (clawback) Policy adopted in connection with its IPO.
- · Simon Allen retired as President and CEO effective December 30, 2025, and remains as Chair of the Board.
- · Philip Moyer was appointed President and CEO effective as of the CEO Transition Date.
- · Tracey Tiska was appointed CHRO effective July 23, 2025.
- · The Board recommends a vote FOR the approval of executive compensation (say-on-pay) and a vote for ONE YEAR as the preferred frequency for advisory votes on executive compensation.
- · The company adopted a clawback policy in connection with its IPO to comply with SEC and NYSE rules.
25-06-2026
Palatin Technologies filed its definitive proxy statement (DEF 14A) for the annual meeting, disclosing fiscal 2025 director and executive compensation, and seeking shareholder ratification of KPMG LLP as independent auditor for FY2026. Director compensation increased sharply over fiscal 2024 levels, while the company reported no new option or stock awards granted to directors or named executive officers during fiscal 2025. Audit fees rose 32.9% year-over-year to $670,000, but tax fees declined 11.2% to $62,702.
- · The company did not grant any new stock options or restricted stock units to directors or named executive officers during fiscal 2025.
- · Chairman option strike price is $91.50 per share, based on June 4, 2024 closing price.
- · Chairman received $29,280 in stock awards and $28,975 in option awards grant date fair value in fiscal 2025.
- · Each other non-employee director received $21,960 in stock awards and $21,416 in option awards grant date fair value.
- · Audit committee chairperson retainer: $20,000 annually; Compensation committee chair: $20,000; Corporate governance committee chair: $10,000.
- · Program development committee pays chair $3,500 per day and members $2,500 per day.
- · No audit-related or other fees were billed by KPMG in either fiscal 2025 or 2024.
- · KPMG has been recommended for ratification as independent auditor for fiscal year ending June 30, 2026.
25-06-2026
LIBERTY ALL STAR EQUITY FUND is seeking shareholder approval at its August 26, 2026 Annual Meeting for a new Portfolio Management Agreement with Loomis, Sayles & Company, L.P., replacing Sustainable Growth Advisers, LP as the large cap growth equity sub-adviser. The fund also proposes to elect two Trustees (Equity Fund) and two Directors (Growth Fund). The proxy solicitation is expected to cost the Equity Fund an estimated $315,000, and the Board unanimously recommends voting FOR all proposals.
- · The new Portfolio Management Agreement with Loomis Sayles commenced on June 15, 2026, after the Sustainable Agreement was terminated on June 14, 2026.
- · The sub-advisory fee rate under the New Agreement is the same as the fee rate paid to Sustainable under the Old Agreement; the fee is paid by AAI, not the Equity Fund.
- · The New Agreement will continue for an initial period ending on the second anniversary of its effective date.
- · The record date for shareholder voting is June 11, 2026.
- · Proxy materials will be mailed on or about July 3, 2026.
25-06-2026
CytoSorbents Corp filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Stockholders to be held virtually on August 13, 2026. Key proposals include the election of five directors, a non-binding advisory vote on executive compensation, ratification of WithumSmith+Brown, PC as independent auditor, approval of a reverse stock split (ratio between 1-for-5 and 1-for-20, at Board discretion), and an adjournment proposal. The filing does not include financial results, so no period-over-period comparisons are available.
- · The reverse stock split ratio range is 1-for-5 to 1-for-20, with the exact ratio set at Board discretion without further stockholder approval, valid for one year from stockholder approval.
- · The record date for voting is June 15, 2026.
- · The virtual meeting will be held at www.virtualshareholdermeeting.com/CTSO2026 with online check-in starting at 9:45 a.m. ET.
- · The proxy materials are available at www.proxyvote.com.
25-06-2026
Hour Loop, Inc. filed a DEF 14A proxy statement for its 2026 annual meeting, seeking shareholder votes on the election of five directors (including CEO Sam Lai) and ratification of HTL International as independent auditor. The filing details voting procedures, quorum requirements (17,595,946 shares needed), and board composition with three of five directors deemed independent.
- · Proposal 1 (election of directors) is a non-routine matter; brokers cannot vote uninstructed shares on this proposal.
- · Proposal 2 (ratification of HTL International) is a routine matter; brokers may vote uninstructed shares.
- · If Proposal 2 is not approved, the audit committee will consider selecting another independent auditor.
- · Directors elected will serve until the 2027 annual meeting.
- · Board unanimously recommends a vote FOR all director nominees and FOR ratification of HTL International.
25-06-2026
Trulieve Cannabis Corp. filed a definitive proxy statement (DEF 14A) on June 25, 2026, for a special meeting of shareholders to be held virtually on August 5, 2026. The primary proposal is to approve a plan of arrangement to redomicile the company from British Columbia, Canada, to Delaware, USA, which would change the governing corporate law and shareholder rights. The board recommends shareholders vote FOR the proposal, but the filing also details potential disadvantages and risk factors associated with the move.
- · The special meeting will be held virtually on August 5, 2026, at 11:00 a.m. Eastern Time.
- · The record date for shareholders entitled to vote is June 8, 2026.
- · Shareholders have dissent rights under the BCBCA; written notice must be received by 5:00 p.m. Vancouver time on July 31, 2026.
- · The proxy statement is being delivered using notice-and-access, posted online rather than mailed.
- · The company's principal executive offices are at 3494 Martin Hurst Road, Tallahassee, Florida 32312.
- · The board recommends a vote FOR the Delaware domestication proposal and FOR the adjournment proposal.
25-06-2026
Tharimmune, Inc. filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Stockholders, detailing seven director nominees, including three new candidates (Sean Galvin, Rishi Nangalia, Pamela L. Carter) to replace outgoing directors Gary Stetz and others. The filing also sets deadlines for stockholder proposals for the 2027 Annual Meeting and reaffirms the combined Chairman and CEO role for Mark Wendland, with a majority-independent board.
- · Stockholder proposals for the 2027 Annual Meeting must be received by February 25, 2027 for inclusion in proxy materials.
- · Director nominations for the 2027 Annual Meeting must be submitted between April 14, 2027 and May 14, 2027.
- · Gary Stetz is not standing for reelection and will cease serving on all board committees upon term expiration.
- · Sean Galvin is expected to serve as Audit Committee Chair and as an audit committee financial expert if elected.
- · William Wiley is expected to serve as Compensation Committee Chair if elected.
- · Jill E. Sommers is expected to serve as Nominating and Governance Committee Chair if elected.
25-06-2026
AIM ImmunoTech Inc. is soliciting stockholder approval for the issuance of more than 19.99% of its outstanding common stock upon exercise of Class H Warrants issued in a May 2026 warrant inducement transaction. The company received approximately $3.5 million in gross proceeds from the exercise of existing warrants at a reduced price of $0.48 per share, while issuing new Class H warrants with a $0.60 exercise price. The filing details procedural aspects of the special meeting, including voting mechanics and proxy solicitation costs, but does not provide any financial performance data or period-over-period comparisons.
- · The special meeting is scheduled for July 2026 with a record date and pre-registration deadline of July 14, 2026 at 11:00 AM Eastern Time.
- · Stockholders can revoke proxies by submitting a later-dated proxy card, written notice to the Corporate Secretary, or attending the virtual meeting.
- · Proxies returned without specific choices will be voted FOR all seven proposals.
- · The company has agreed to file a resale registration statement for Class H Warrant Shares within 30 days of closing and use best efforts to have it effective within 60-90 days.
- · The warrant inducement transaction closed on May 8, 2026.
25-06-2026
Eaton Vance Municipal Bond Fund (EIM) filed a definitive proxy statement (DEF 14A) on June 25, 2026, for its Annual Meeting of Shareholders to be held on August 18, 2026. The primary proposal is the election of three Class III Trustees: Alan C. Bowser, George J. Gorman, and Marcus L. Smith. As of the record date June 4, 2026, there were 51,372,599 common shares outstanding, with no shareholder owning 5% or more and trustees/executive officers owning less than 1% collectively.
- · The Board of Trustees has fixed the number of Trustees at nine, divided into three classes with staggered three-year terms.
- · As of June 4, 2026, no shareholder owned 5% or more of outstanding Common Shares, and Trustees and executive officers collectively owned less than 1%.
- · The Annual Meeting will be held on Tuesday, August 18, 2026 at 11:30 a.m. Eastern Time at One Post Office Square, Boston, Massachusetts 02109.
- · Shareholders of record as of June 4, 2026 are entitled to vote; proxies must be received prior to the meeting.
- · The Board recommends voting FOR the election of each Trustee nominee.
25-06-2026
Granite Ridge Resources, Inc. is holding a Special Meeting on August 4, 2026 to seek stockholder approval for reincorporation from Delaware to Texas by conversion. The Board unanimously recommends voting FOR the proposal. As of the record date, there are 131,895,990 shares of common stock outstanding, each entitled to one vote.
- · Special Meeting will be virtual only via live webcast at https://www.cstproxy.com/graniteridge/sm2026.
- · Record date for voting is June 15, 2026.
- · Approval requires a majority of outstanding shares voted FOR the proposal.
- · Abstentions count as votes AGAINST the proposal.
- · No broker non-votes are expected as the proposal is non-routine and no routine matters are on the agenda.
- · The company's principal offices are at 5217 McKinney Avenue, Suite 400, Dallas, Texas 75205.
25-06-2026
Liberty All Star Growth Fund Inc. filed a definitive proxy statement (DEF 14A) for its 2026 Joint Annual Meeting to be held on August 26, 2026. The meeting includes a key proposal from the Equity Fund to approve a new Portfolio Management Agreement with Loomis, Sayles & Company, L.P., replacing the previous sub-adviser Sustainable Growth Advisers, LP. The Boards unanimously recommend voting FOR all proposals; however, the meeting notice highlights that the additional proxy solicitation costs for this proposal, estimated at $315,000, will be borne solely by the Equity Fund shareholders.
- · Proxy statement is available online at https://vote.proxyonline.com/libertyallstarfunds/docs/2026am.pdf
- · Equity Fund currently has five Portfolio Managers; the change introduces Loomis Sayles for large cap growth equity allocation.
- · Shareholders of record as of June 11, 2026 are eligible to vote.
- · The new Portfolio Management Agreement fee rate for Loomis Sayles is the same as the fee rate paid to Sustainable Growth Advisers.
- · The solicitation is being mailed on or about July 3, 2026.
- · Equity Fund shareholders bear the estimated $315,000 additional proxy solicitation costs; regular meeting costs are shared by both Funds.
- · The old Portfolio Management Agreement with Sustainable was terminated on June 14, 2026; the new agreement with Loomis Sayles commenced on June 15, 2026, subject to shareholder approval.
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 15 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Executive Compensation Proxy SEC Filings
🇺🇸 More from United States
View all →June 18, 2026
US Pre-Market SEC Filings Roundup — June 18, 2026
US Pre-Market SEC Filings Roundup
June 18, 2026
US Corporate Distress Financial Stress SEC Filings — June 18, 2026
US Corporate Distress Financial Stress SEC Filings
June 18, 2026
US IPO Pipeline SEC S-1 Filings — June 18, 2026
US IPO Pipeline SEC S-1 Filings
June 18, 2026
US Merger & Acquisition SEC Filings — June 18, 2026
US Merger & Acquisition SEC Filings